0
Abstract: Slide Presentations |

PLASMA THYMUS AND ACTIVATION REGULATED CHEMOKINE IN ASTHMA EXACERBATION FREE TO VIEW

Maged M. Eissa, MD*; Wafaa A. El-Neanaey, MD; Salwa M. Amer, MBBCh
Author and Funding Information

Faculty of Medicine, Alexandria University, Alexandria, Egypt


Chest


Chest. 2008;134(4_MeetingAbstracts):s23003. doi:10.1378/chest.134.4_MeetingAbstracts.s23003
Text Size: A A A
Published online

Abstract

PURPOSE:Plasma Thymus and Activation Regulated Chemokine (TARC)is responsible for the trafficking of TH2 lymphocytes into sites of allergic inflammation. Recent studies suggested that TARC is a useful marker for chronic asthma, however, its role in asthmatic exacerbation is still unknown. The aim was to measure plasma concentration of TARC in asthmatic exacerbation, correlate the concentration with the severity of exacerbation, and to compare it with its level in stable condition and in normal controls.

METHODS:Plasma TARC concentration was assayed by ELISA in 30 asthmatic children during exacerbation, they were divided into three groups (mild, moderate and severe exacerbation) and in 20 healthy controls. The level was re-measured after control of exacerbation (stable condition). Peak Expiratory Flow Rate (PEFR), absolute eosinophilic count, oxygen concentration and total IgE were also measured in cases and controls.

RESULTS:Mean plasma TARC level in asthmatic exacerbation (409.3±248.3 pg/ml) was statistically significantly higher than its mean level in stable condition (96.2±126.7 pg/ml), and in controls (39.6±22.2 pg/ml) P = <0.0001. Also mean plasma TARC level was statistically significantly higher in stable condition than in controls, P= 0.05. Mean plasma TARC level in severe exacerbation ( 496.6±321.6 pg/ml) was higher than its mean level in moderate exacerbation (459.1±238.7 pg/ml) and in mild exacerbation (279.8±140.7 pg/ml) however, the difference was not statistically significant P = 0.12 .

CONCLUSION:Plasma TARC is elevated in asthmatic exacerbation but is not correlated with its severity.

CLINICAL IMPLICATIONS:Plasma TARC can be used to monitor occurence of asthma exacerbation but can not be used to assess its severity.

DISCLOSURE:Maged Eissa, No Financial Disclosure Information; No Product/Research Disclosure Information

Monday, October 27, 2008

2:30 PM - 4:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543